| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Manson Dean | CHIEF LEGAL OFFICER | 9601 S. MERIDIAN BLVD., ENGLEWOOD | /s/ Dean A. Manson, by Daniel W. Conroy, Attorney-in-Fact | 09 Mar 2026 | 0001353333 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SATS | Class A Common Stock | Options Exercise | +7,631 | +318% | $14.04* | 10,029 | 05 Mar 2026 | Direct | ||
| transaction | SATS | Class A Common Stock | Sale | $873,826 | -7,631 | -76% | $114.51 | 2,398 | 05 Mar 2026 | Direct | F1 |
| transaction | SATS | Class A Common Stock | Options Exercise | +14,000 | +584% | $14.04* | 16,398 | 05 Mar 2026 | Direct | ||
| transaction | SATS | Class A Common Stock | Sale | $1,306,440 | -11,400 | -70% | $114.60 | 4,998 | 05 Mar 2026 | Direct | F2 |
| holding | SATS | Class A Common Stock | 1,106 | 05 Mar 2026 | I | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SATS | Employee Stock Option (Right to Buy) | Options Exercise | -7,631 | -16% | $0.000000* | 39,700 | 05 Mar 2026 | Class A Common Stock | 7,631 | $14.04 | Direct | F4 | |
| transaction | SATS | Employee Stock Option (Right to Buy) | Options Exercise | -14,000 | -25% | $0.000000* | 42,000 | 05 Mar 2026 | Class A Common Stock | 14,000 | $14.04 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $114.31 to $114.80. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F2 | Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $114.33 to $114.80. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F3 | By 401(K). |
| F4 | 40% of the shares underlying these options vested immediately upon the grant date. The remaining 60% of the shares underlying these options vest 30% per year on each of April 1, 2025 and April 1, 2026. |
| F5 | The shares underlying these options vest 25% per year on each of April 1, 2025, April 1, 2026, April 1, 2027 and April 1, 2028. |